Sai Life Sciences Complete Financial Statements

SAILIFE • Review detailed financials to uncover trends, confirm thesis & journal trades
7 Years of Data
2025 - 2019

Complete Financial Data Export

Export complete financial statements for Sai Life Sciences (SAILIFE). Downloads include all available records across all periods.

Profitability Ratios

Net Profit Margin 15.19% 2025 data
EBITDA Margin 29.11% 2025 data
Operating Margin 27.00% 2025 data
Return on Assets 2.66% 2025 data
Return on Equity 3.95% 2025 data

Balance Sheet Ratios

Current Ratio 5.03 2025 data
Equity Ratio 67.34% 2025 data
Asset Turnover 0.18 2025 data

Year-over-Year Growth Analysis

Comparing Sept 2024 vs Sept 2025
Revenue Growth
+36.2%
Year-over-Year
Net Profit Growth
+100.0%
Year-over-Year
EBITDA Growth
+43.8%
Year-over-Year
Expense Growth
+33.8%
Year-over-Year
Assets Growth
+38.9%
Year-over-Year
Equity Growth
+118.3%
Year-over-Year
Operating Cash Flow Growth
+19.4%
Year-over-Year
Investing Cash Flow Growth
-180.6%
Year-over-Year
Financing Cash Flow Growth
+416.8%
Year-over-Year

Income Statement

Periods ₹ Crores
Particulars Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Dec 2023
Revenue 553 589 506 565 406 443 288 449 395
Expenses 392 422 376 377 293 315 254 320 287
EBITDA 161 167 131 188 112 128 34 129 108
Operating Profit Margin % 27.00% 27.00% 24.00% 32.00% 26.00% 28.00% 9.00% 27.00% 25.00%
Depreciation 40 38 38 44 36 31 31 34 31
Interest 9 11 12 10 21 21 21 23 23
Profit Before Tax 112 119 81 134 55 76 -18 72 53
Tax 28 31 20 34 14 20 -5 18 13
Net Profit 84 88 61 100 42 56 -14 54 40
Earnings Per Share (₹) 4.01 4.24 2.90 4.77 2.22 31.00 -0.74 2.89 2.19

Balance Sheet

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020 2019
ASSETS
Total Assets 3,160 2,275 2,177 2,157 1,817 1,410 1,216
Current Assets 1,505 945 962 944 804 613 691
Fixed Assets 1,488 1,180 789 751 701 641 374
Capital Work in Progress 125 107 399 410 246 91 116
Investments 2 2 2 0 0 0 0
Other Assets 1,545 987 987 997 870 679 726
LIABILITIES
Total Liabilities
Current Liabilities 299 560 532 565 356 149 160
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 2,128 975 888 879 863 794 720
Share Capital 21 18 18 18 18 16 16
Reserves & Surplus 2,108 957 870 861 845 777 703

Cash Flow Statement

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019
Operating Activities 314 263 219 105 -36 116 129
Investing Activities -536 -191 -99 -102 -260 -262 -158
Financing Activities 301 -95 -201 72 296 -4 268
Net Cash Flow 79 -24 -80 75 -1 -150 239